Cite Filings / STLN / 0001628280-22-031241

Feed Companies Filings Check

Sign in

424B3

Prospectus

Starling Oncology, Inc. Filed 2022-12-01 Acc 0001628280-22-031241

Documents 1

424B3 Prospectus , a4248k-caoxnote.htm

Around this filing

2023-01-09 424B3 Prospectus
2022-12-08 4 President acquired 350,000 shares (option exercise)
2022-12-01 424B3 Prospectus
2022-12-01 424B3 Prospectus
2022-12-01 424B3 Prospectus
2022-12-01 8-K Executive or director change

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading a4248k-caoxnote.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…